Alzheimer's disease Trials in Lake Worth, United States
Conditions / Alzheimer's disease / Lake Worth, United States
Research into Alzheimer's disease spans multiple therapeutic approaches and trial phases.
19 total trials for this combination
Showing top 10 of 19 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02670083 | A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD). | TERMINATED | PHASE3 |
| NCT02079246 | Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease | COMPLETED | PHASE3 |
| NCT03114657 | A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) | TERMINATED | PHASE3 |
| NCT02080364 | Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT01767311 | A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease | COMPLETED | PHASE2 |
| NCT01969123 | Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease | TERMINATED | PHASE3 |
| NCT01741194 | AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext | COMPLETED | PHASE2/PHASE3 |
| NCT02006641 | Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil | COMPLETED | PHASE3 |
| NCT03036280 | A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Subjects With Early Alzheimer's Disease_ | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02245737 | An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease | TERMINATED | PHASE2/PHASE3 |